Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 5 of 5
Full-Text Articles in Dentistry
Proliferative Verrucous Leukoplakia Progressing To Squamous Cell Carcinoma: A Case Report, Magdalena Orlowska Dds, Felipe Nör Dds, Ms, Phd, Robert Eber Dds, Ms, Stepanie Munz Dds, David Tindle Dds, Ms
Proliferative Verrucous Leukoplakia Progressing To Squamous Cell Carcinoma: A Case Report, Magdalena Orlowska Dds, Felipe Nör Dds, Ms, Phd, Robert Eber Dds, Ms, Stepanie Munz Dds, David Tindle Dds, Ms
The Journal of the Michigan Dental Association
Proliferative verrucous leukoplakia (PVL) is an uncommon type of oral leukoplakia characterized by white patches featuring verrucoid areas. It is a condition of idiopathic origin, displaying a strong tendency to transform into squamous cell carcinoma, verrucous carcinoma, or the newly described particulate carcinoma. PVL is more commonly found in elderly women who have had leukoplakic lesions for many years. Although PVL may be found virtually anywhere in the oral cavity, the buccal mucosa, gingiva, and tongue are the most common sites. In this case, we describe a lesion of this nature found in an elderly male patient. PVL is difficult …
Peripheral Ameloblastoma: Case Report And Literature Review, Anna Cappell Cooper Ba, Daria Vasilyeva Dds, Khanh Trinh Dmd, Elizabeth Philipone Dmd
Peripheral Ameloblastoma: Case Report And Literature Review, Anna Cappell Cooper Ba, Daria Vasilyeva Dds, Khanh Trinh Dmd, Elizabeth Philipone Dmd
The New York State Dental Journal
Peripheral ameloblastoma is a benign, painless, and slow-growing odontogenic tumor, which commonly affects gingival soft tissues or edentulous alveolar areas. Peripheral ameloblastoma is typically found during the 5th to 7th decades of life, with a mean patient age of 52 years, and exhibits a male predilection. Histopathology features are consistent with those of conventional ameloblastoma. The treatment of choice is conservative surgical excision with minimal disease-free margins and appropriate follow-up.
Squamous Odontogenic Tumor: A Case Report, Sara Endo Dds, Timothy Chang Dds, Daria Vasilyeva Dds, Scott M. Peters Dds
Squamous Odontogenic Tumor: A Case Report, Sara Endo Dds, Timothy Chang Dds, Daria Vasilyeva Dds, Scott M. Peters Dds
The New York State Dental Journal
Squamous odontogenic tumors (SOT) are slow-growing, benign, rare intraosseous neoplasms. SOT are typically found in the premolar-canine region of the maxilla and the molar region of the mandible. These lesions have no gender predilection and show peak occurrence in the third decade of life.
Sulfamethoxazole-Trimethoprim Induced Thrombocytopenia: A Report Of Two Cases And A Literature Review, Leigh Griffin Dds, Michael Graffeo Dds, Jay Sher Dds, Paul D. Freedman Dds, Renée F. Reich
Sulfamethoxazole-Trimethoprim Induced Thrombocytopenia: A Report Of Two Cases And A Literature Review, Leigh Griffin Dds, Michael Graffeo Dds, Jay Sher Dds, Paul D. Freedman Dds, Renée F. Reich
The New York State Dental Journal
Sulfamethoxazole- trimethoprim (ST) is a sulfonamide derivative antibiotic that interferes with bacterial folic acid synthesis and growth by blocking dihydrofolic acid formation from para-aminobenzoic acid. One of the potential side effects of sulfamethoxazole-trimethoprim is thrombocytopenia. Thrombocytopenia is a blood disorder characterized by a decreased number of circulating platelets. We present two cases of ST induced thrombocytopenia where the oral manifestations were the first indication of the low platelet count leading to life saving interventions. Our aim is to educate dentists about the oral manifestations of thrombocytopenia and its association with ST as their examination may be instrumental in directing treatment.
Oral Manifestations Of Metastatic Diseases: A Clinical And Histologic Analysis Of 7 Cases, Zeming Zheng Dds, Elizabeth Philipone Dmd
Oral Manifestations Of Metastatic Diseases: A Clinical And Histologic Analysis Of 7 Cases, Zeming Zheng Dds, Elizabeth Philipone Dmd
The New York State Dental Journal
Metastatic diseases comprise 1-3% of malignant oral neoplasms with nearly one-third of patients being unaware of having a primary cancer1-4,9. This retrospective analysis identified all oral lesions diagnosed as metastatic disease in the CDM Department of Oral Pathology’s oral biopsy database from 2015-2020 and reported on patient demographics, clinical presentation and diagnosis, origin of the primary, and whether the patient had known history of the disease. From 17,500 total cases, 7 cases were identified as metastatic disease and described in detail. Clinicians’ recognition and awareness of these lesions’ often evasive, ambiguous oral presentations may help facilitate diagnosis, treatment, and prognosis.